SiteOne Therapeutics competitors
SiteOne Therapeutics Competitors include U.S. Stem Cell, Cannabis Sativa, Pfenex and CEL-SCI.
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  SiteOne Therapeutics SiteOne Therapeutics is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids |  U.S. Stem Cell U.S. Stem Cell is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. |  Cannabis Sativa Cannabis Sativa, Inc is engaged in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. |  Pfenex Pfenex is a clinical-stage biotechnology company developing and commercializing high-value and difficult to manufacture proteins. |  CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. |
Founding Date | Founding Date 2010 | Founding Date N/A | Founding Date 2012 | Founding Date 2009 | Founding Date 1983 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Bozeman, US HQ | Locations Sunrise, US HQ | Locations Mesquite, US HQ | Locations San Diego, US HQ | Locations Vienna, US HQ |
Employees | Employees N/A | Employees 3 | Employees 2 | Employees 649% decrease | Employees 43 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 9.5 m | Valuation ($) 56.8 m | Valuation ($) 158.9 m | Valuation ($) 80 m |
Facebook likes | Facebook likes N/A | Facebook likes 1.4 k | Facebook likes 10.9 k | Facebook likes 5.7 k | Facebook likes N/A |
Twitter followers | Twitter followers N/A | Twitter followers 1.8 k | Twitter followers 107 | Twitter followers 9.2 k | Twitter followers 188 |
Financial ⚠ | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $5.5m (FY, 2017) | Revenue (est.) $11.6k (FY, 2015) | Revenue (est.) $28.8m (FY, 2017) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $1.9m (FY, 2017) | Cost of goods $5.8k (FY, 2015) | Cost of goods $5.2m (FY, 2017) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $3.6m (FY, 2017) | Gross profit $5.8k (FY, 2015) | Gross profit $23.6m (FY, 2017) | Gross profit N/A |
Net income | Net income N/A | Net income ($3.5m) (FY, 2017) | Net income ($7.4m) (FY, 2015) | Net income ($25.7m) (FY, 2017) | Net income ($14.4m) (FY, 2017) |
Funding | |||||
Total funding raised | Total funding raised $ 17.8m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 24m | Total funding raised N/A |
For sources of this data, please see the company profileDownload Excel
View company profiles
U.S. Stem Cell
HQ
Sunrise, US
Employees
3
U.S. Stem Cell is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.
View companyCannabis Sativa
HQ
Mesquite, US
Employees
2
Cannabis Sativa, Inc is engaged in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems.
View companyPfenex
HQ
San Diego, US
Employees
64↓ 9% decrease
Pfenex is a clinical-stage biotechnology company developing and commercializing high-value and difficult to manufacture proteins.
View companyCEL-SCI
HQ
Vienna, US
Employees
43
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
View company